Recent PLSE News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:25:39 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2024 08:18:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 09:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:15:28 PM
- Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results • Business Wire • 08/12/2024 08:05:00 PM
- Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors • Business Wire • 08/12/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 01:09:58 PM
- Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System • Business Wire • 08/08/2024 12:00:00 PM
- Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences • Business Wire • 08/01/2024 08:05:00 PM
- Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024 • Business Wire • 07/29/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/23/2024 01:06:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 11:10:01 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/15/2024 11:04:10 AM
- Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)] • Edgar (US Regulatory) • 07/15/2024 10:05:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 01:12:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 01:56:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 01:54:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:13:08 PM
- Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation • Business Wire • 07/08/2024 12:00:00 PM
- Pulse Biosciences, Inc. Announces the Closing of its Rights Offering • Business Wire • 07/03/2024 06:44:00 PM
- Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering • Business Wire • 06/28/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:16:33 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 06/04/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:04:46 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/03/2024 04:15:14 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM